Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CORONAVIRUS VACCINES AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/110099
Kind Code:
A1
Abstract:
This disclosure relates to coronavirus vaccines and uses thereof. In one aspect, the disclosure provides a nucleic acid vaccine, comprising a sequence encoding a spike protein or fragment thereof derived from a coronavirus.

Inventors:
ZHANG BILL BILIANG (CN)
LI MAN (CN)
MA LIN (CN)
WEN JIAN (CN)
ZHANG HONG (CN)
ZHONG HUILING (CN)
Application Number:
PCT/CN2020/132609
Publication Date:
June 02, 2022
Filing Date:
November 30, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGZHOU ARGORNA BIOPHARMACEUTICALS CO LTD (CN)
International Classes:
C07K19/00; C07K14/165; C12N15/50
Foreign References:
CN110352071A2019-10-18
US20200188475A12020-06-18
US10392341B22019-08-27
US8802644B22014-08-12
Other References:
ZHANG DONG YAN, WANG JIAN, DOKHOLYAN NIKOLAY V.: "Prefusion spike protein stabilization through computational mutagenesis", PROTEINS: STRUCTURE, FUNCTION, AND BIOINFORMATICS, JOHN WILEY & SONS, INC., US, vol. 89, no. 4, 1 April 2021 (2021-04-01), US , pages 399 - 408, XP055936466, ISSN: 0887-3585, DOI: 10.1002/prot.26025
HSIEH CHING-LIN, GOLDSMITH JORY A, SCHAUB JEFFREY M, DIVENERE ANDREA M, KUO HUNG-CHE, JAVANMARDI KAMYAB, LE KEVIN C, WRAPP DANIEL,: "Structure-based design of prefusion-stabilized SARS-CoV-2 spikes", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 369, no. 6510, 18 September 2020 (2020-09-18), US , pages 1501 - 1505, XP055780339, ISSN: 0036-8075, DOI: 10.1126/science.abd0826
WRAPP DANIEL, WANG NIANSHUANG, CORBETT KIZZMEKIA S., GOLDSMITH JORY A., HSIEH CHING-LIN, ABIONA OLUBUKOLA, GRAHAM BARNEY S., MCLEL: "Cryo-EMstructure of the 2019-nCo Vspike in the prefusion conformation", SCIENCE, 19 February 2020 (2020-02-19), pages 1260 - 1263, XP055829067, Retrieved from the Internet [retrieved on 20210730], DOI: 10.1126/science.abb2507
MAO YAPING , BIAN DAWEI: "Bioinformatics Analysis of Mutations in the Spike Protein of SARS-CoV- 2 and Their Effects", CHINESE JOURNAL OF VIROLOGY, vol. 36, no. 6, 11 November 2020 (2020-11-11), pages 1020 - 1027, XP055936542, ISSN: 1000-8721, DOI: 10.13242/j.cnki.bingduxuebao.003822
XIN LI, GUANGYOU DUAN, WEI ZHANG, JINSONG SHI, JIAYUAN CHEN, SHUNMEI CHEN, SHAN GAO, JISHOU RUAN: "A furin cleavage site was discovered in the S protein of the 2019 novel coronavirus", CHINESE JOURNAL OF BIOINFORMATICS, vol. 18, no. 2, 30 June 2020 (2020-06-30), pages 103 - 108, XP055936473, DOI: https://doi.org/10.12113/202002001
OKBA NMAMULLER MALI W ET AL.: "Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients", EMERG INFECT DIS, vol. 26, no. 7, 8 April 2020 (2020-04-08)
ZHOU PYANG XLWANG XG ET AL.: "A pneumonia outbreak associated with a new coronavirus of probable bat origin", NATURE, vol. 579, no. 7798, March 2020 (2020-03-01), pages 270 - 273, XP037296454, DOI: 10.1038/s41586-020-2012-7
HOFFMANN MKLEINE-WEBER HSCHROEDER S ET AL.: "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor", CELL, 4 March 2020 (2020-03-04)
YAMAMOTO ET AL., J. EXP. MED., vol. 185, 1997, pages 1203 - 1210
DI TOMMASO ET AL., INFECT. IMMUNITY, vol. 64, 1996, pages 974 - 979
See also references of EP 4034548A4
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF: